Table 4. Changes in BP from baseline after 16 weeks of olmesartan-based treatment in patients aged⩾75 years.
|
Morning home BPa |
P-valueb |
Clinic BPa |
P-valueb | |||
|---|---|---|---|---|---|---|
| Baseline | 16 Weeks | Baseline | 16 Weeks | |||
| Patients with masked hypertension (n=611) | ||||||
| Systolic BP (mm Hg) | 148.7±11.3 | 137.5±14.3 | <0.0001 | 129.0±8.5 | 129.7±14.9 | 0.2462 |
| Diastolic BP (mm Hg) | 79.7±9.7 | 74.8±9.6 | <0.0001 | 71.3±10.0 | 70.4±10.3 | 0.0219 |
| Patients with white coat hypertension (n=230) | ||||||
| Systolic BP (mm Hg) | 128.0±5.3 | 132.3±12.6 | <0.0001 | 151.6±11.0 | 139.7±16.5 | <0.0001 |
| Diastolic BP (mm Hg) | 71.2±8.1 | 72.2±9.7 | 0.0898 | 78.5±10.9 | 72.7±10.4 | <0.0001 |
| Patients with poor-controlled hypertension (n=3101) | ||||||
| Systolic BP (mm Hg) | 156.8±13.2 | 138.7±13.8 | <0.0001 | 159.8±14.3 | 138.8±15.4 | <0.0001 |
| Diastolic BP (mm Hg) | 83.2±10.3 | 75.0±9.3c | <0.0001 | 83.7±11.6 | 74.2±10.1 | <0.0001 |
| Patients with well-controlled hypertension (n=337) | ||||||
| Systolic BP (mm Hg) | 124.5±7.3 | 129.0±12.4 | <0.0001 | 124.4±10.0 | 128.9±14.4 | <0.0001 |
| Diastolic BP (mm Hg) | 70.2±8.2 | 72.0±9.5 | 0.0004 | 69.1±9.0 | 70.9±9.9 | 0.0019 |
Abbreviation: BP, blood pressure.
a
Mean±s.d.
b
Data analyzed by paired t-test.
c
Two patients had missing values.